Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vincent Umbrain is active.

Publication


Featured researches published by Vincent Umbrain.


Anaesthesia | 2000

Isoflurane, desflurane and sevoflurane for carotid endarterectomy

Vincent Umbrain; J. Keeris; J. D'Haese; C. Verborgh; E. Debing; P. Van den Brande; F. Camu

After carotid endarterectomy under general anaesthesia, the rapid elimination of desflurane and sevoflurane may allow earlier postoperative neurological assessment than after the use of isoflurane. However, desflurane may be associated with tachycardia and hypertension and may therefore increase cardiovascular risk. We investigated haemodynamic and recovery characteristics in patients scheduled for carotid endarterectomy who were anaesthetised with isoflurane, sevoflurane or desflurane. No significant peri‐operative differences were noted in cardiac index or ST segment analysis. The times to extubation, movement on command and consciousness were shorter after desflurane and sevoflurane than after isoflurane anaesthesia. Postoperative pain, nausea, vomiting and shivering were similar in the three study groups.


Scandinavian Journal of Urology and Nephrology | 2010

Bipolar transurethral resection in saline: The solution to avoid hyponatraemia and transurethral resection syndrome

Dirk P.J. Michielsen; Danny Coomans; Johan Braeckman; Vincent Umbrain

Abstract Objective. To compare serum sodium changes and the incidence of transurethral resection (TUR) syndrome after monopolar transurethral resection of the prostate (TURP) and bipolar transurethral resection in saline (TURIS) for symptomatic benign prostatic hyperplasia. Material and methods. Between January 2005 and August 2009, 550 consecutive patients with symptomatic benign prostate hyperplasia underwent TURP, by either a monopolar or bipolar technique. Preoperative and postoperative blood parameters were analysed to compare preoperative and postoperative electrolyte concentrations. Results. Over 56 months, 265 patients underwent a conventional monopolar TURP and 285 patients had a bipolar TURIS (Olympus). Patient profiles regarding age, operation time, resection weight and resection speed were similar in both groups. A drop in sodium of 2.5 mmol/l was measured in the conventional monopolar resection group. The decline of 1.5 mmol/l in the bipolar group, although smaller, was still statistically significant (p = 0.001). With longer operation times (> 1 h) the difference between the groups became more important (p < 0.001). Two clinical TUR syndromes were observed in the monopolar group, while none occurred in the bipolar group. Conclusions. Bipolar TURP in saline is a safe technique and obviates the risk of TUR syndrome. Repeated serum analysis of electrolytes after TURIS can be omitted.


Pain | 2006

Peripheral inflammation modifies the effect of intrathecal il-1β on spinal PGE2 production mainly through cyclooxygenase-2 activity. A spinal microdialysis study in freely moving rats

Lin Shi; Ilse Smolders; Vincent Umbrain; Mary Helen Lauwers; Sophie Sarre; Yvette Michotte; Martin Zizi; F. Camu

Abstract Acute inflammation induces upregulation of IL‐1&bgr; both at the site of the peripheral inflammation and in the cerebrospinal fluid (CSF). The central increase of IL‐1&bgr; mainly contributes to the development of hypersensitivity. However, the spinal mechanisms for the effects of IL‐1&bgr; in nociceptive transmission are incompletely understood. It is also unknown whether previous sensitization changes IL‐1&bgr; activity. We therefore investigated the dose–effect relationship of intrathecal (i.t.) IL‐1&bgr; on spinal PGE2 production in the absence and presence of peripheral formalin inflammation with spinal microdialysis in freely moving rats. The possible involvement of cyclooxygenase (COX) isoforms in the IL‐1&bgr;‐mediated spinal PGE2 production on the background of peripheral formalin inflammation was further evaluated with the selective COX‐1 and COX‐2 inhibitors. We found that the i.t. administration of IL‐1&bgr;, with doses of 1, 2, 8, or 16 ng, increased PGE2 levels in CSF in a dose‐related fashion. This IL‐1&bgr;‐evoked PGE2 release occurred within 30 min after IL‐1&bgr; administration, peaked at 30–60 min interval, and returned gradually to the baseline level within 4 h. Peripheral formalin inflammation in the paw induced a more prolonged effect of spinal IL‐1&bgr; with larger PGE2 releases in the CSF compared with the non‐inflammatory state, suggesting that peripheral inflammation enhances central sensitization. The COX‐2 inhibitor SC58236 (15 mg/kg) reduced the IL‐1&bgr;‐mediated PGE2 increase in CSF by 86% while the COX‐1 inhibitor SC58560 (15 mg/kg) had less effect (28%). Our study suggests that mainly the COX‐2 enzyme mediates the IL‐1&bgr;‐induced increase in spinal PGE2 in the presence of peripheral formalin inflammation.


Europace | 2016

One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience

Ghazala Irfan; Carlo de Asmundis; Giacomo Mugnai; Jan Poelaert; Christian Verborgh; Vincent Umbrain; Stefan Beckers; Ebru Hacioglu; Burak Hunuk; Vedran Velagic; Erwin Ströker; Pedro Brugada; Gian-Battista Chierchia

AIM The second-generation cryoballoon (CB-Adv) is effective in achieving pulmonary vein isolation (PVI) with encouraging results. In this study, we assessed the single-procedure outcome on a 1-year follow-up period in a large sample of patients having undergone PVI for drug-resistant atrial fibrillation (AF) using the CB-Adv. METHODS AND RESULTS A total of 393 patients (122 female, 31%; mean age 57.7 ± 12.9 years) with drug-refractory AF undergoing PVI using the novel CB-Adv were enrolled. Follow-up was based on outpatient clinic visits including Holter electrocardiograms. Recurrence of atrial tachyarrhythmias (ATas) was defined as a symptomatic or documented episode >30 s. A total of 1572 pulmonary veins (PVs) were identified and successfully isolated with 1.2 ± 0.3 mean freezes. Mean procedure and fluoroscopy times were 87.1 ± 38.2 and 14.9 ± 6.1 min, respectively. At a mean follow-up of 12 months, freedom from ATas after a single procedure was achieved in 85.8% of patients with paroxysmal atrial fibrillation and in 61.3% of patients with persistent AF (persAF). Similar success rates were observed between bonus freeze and single freeze strategies, 82.5 and 81.8%, respectively (P = 0.9). Multivariate analysis demonstrated that persAF (P = 0.04) and relapses during blanking period (BP) (P < 0.0001) were independent predictors of ATas recurrences. CONCLUSION Freedom from any ATa can be achieved in 81.9% of patients after a single CB-Adv procedure in a large cohort of patients. A bonus freeze does not influence the clinical outcome, and reducing the duration of the cryoapplication to 3 min offers excellent results. Persistent AF and arrhythmia recurrence during the BP are strong predictors of AF recurrence.


Regional Anesthesia and Pain Medicine | 2004

Ropivacaine 3.75 mg/mL, 5 mg/mL, or 7.5 mg/mL for Cervical Plexus Block During Carotid Endarterectomy

Vincent Umbrain; Viola Van Gorp; Eric Schmedding; Erik Debing; Karl von Kemp; Pierre Van den Brande; F. Camu

Objective To examine the effect of 225 mg (7.5 mg/mL), 150 mg (5 mg/mL), and 112.5 mg (3.75 mg/mL) ropivacaine on quality of cervical plexus block during carotid endarterectomy. Methods Patients (n = 93) scheduled for carotid endarterectomy were randomized to receive a cervical plexus block with deep infiltration of 10 mL and superficial infiltration of 20-mL volumes of ropivacaine 7.5, 5.0, or 3.75 mg/mL. Pain, coughing, hemodynamic consequences of the block, postoperative visual analog scores, and pain satisfaction index were recorded. If necessary, anesthesia supplements with aliquots of 3 mL lidocaine 1% were given during surgery. Results Incidences of coughing and hoarseness were similar in all groups. More local anesthetic infiltrations were required in the ropivacaine 3.75-mg/mL and 5-mg/mL groups. Postoperatively, no intragroup differences were observed. A trend toward better pain satisfaction was observed in the ropivacaine 7.5-mg/mL group. Conclusion The best quality of cervical plexus block associated with the smallest incidence of pain for patients undergoing carotid endarterectomy was obtained with 30 mL of 225 mg and 150 mg of ropivacaine, respectively.


Europace | 2016

Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience.

Carlo de Asmundis; Gian-Battista Chierchia; Giacomo Mugnai; Ines Van Loo; Jan Nijs; Jens Czapla; Giulio Conte; Vedran Velagic; Moises Rodrigues Mañero; Giuseppe Ciconte; Erwin Ströker; Vincent Umbrain; Jan Poelaert; Pedro Brugada; Mark La Meir

Aims The purpose of this study was to analyse the efficacy and complication rates of the simultaneous hybrid procedure in a series of patients with persistent and long-standing persistent atrial fibrillation (AF) in a midterm follow-up. Methods and results Sixty-four consecutive patients (56 males, 59.7 ± 8.7 years) having undergone isolation of pulmonary veins (PVs) and posterior wall of left atrium (LA) by means of hybrid thoracoscopic ablation for symptomatic persistent (n = 21, 33%) and long-standing persistent AF (n = 43, 67%) were analysed. At a mean follow-up of 23.1 ± 14.1 months (median 21; range 6–57), the success rate without antiarrhythmic therapy was achieved in 67.2% of patients. Procedure-related complications were observed in 13 patients (20.3%) including 2 LA perforations (3.1%) requiring, respectively, conversion to sternotomy and small left-sided thoracotomy. The success rate did not significantly differ between persistent and long-standing persistent AF (respectively, 71.4 and 65.1%; P = 0.4). Patients with AF relapse during the blanking period were 4.60 times more likely to have AF recurrence after 3 months from the ablation procedure. Conclusion The hybrid procedure yields promising results in the setting of both persistent and long-standing persistent AF after midterm follow-up, at the expense of a non-negligible rate of adverse events. Our findings need to be confirmed by further larger and prospective studies.


Pacing and Clinical Electrophysiology | 2013

Safe single-dose administration of propofol in patients with established brugada syndrome: a retrospective database analysis.

Panagiotis Flamée; Carlo de Asmundis; Jigme T. Bhutia; Giulio Conte; Stefan Beckers; Vincent Umbrain; Christian Verborgh; Gian-Battista Chierchia; Sophie Van Malderen; Rubén Casado-Arroyo; Andrea Sarkozy; Pedro Brugada; Jan Poelaert

Propofol is an anesthetic drug with a very attractive pharmacokinetic profile, which makes it the induction agent of choice, especially in day‐case surgery. Data on its potential proarrhythmic effects in patients with Brugada syndrome (BS) patients are still lacking. The aim of our study was to investigate whether a single dose of propofol triggered any adverse events in consecutive high‐risk patients with BS.


Europace | 2016

Incidence of real-time recordings of pulmonary vein potentials using the third-generation short-tip cryoballoon.

Gian-Battista Chierchia; Giacomo Mugnai; Erwin Ströker; Vedran Velagic; Burak Hünük; Darragh Moran; Ebru Hacioglu; Jan Poelaert; Christian Verborgh; Vincent Umbrain; Stefan Beckers; Diego Ruggiero; Pedro Brugada; Carlo de Asmundis

AIMS The third-generation Cryoballoon Advance Short-tip (CB-ST) has been designed with a 40% shortened tip length compared with the former second-generation CB Advance device. Ideally, a shorter tip should permit an improved visualization of real-time (RT) recordings in the pulmonary vein (PV) due to a more proximal positioning of the inner lumen mapping catheter. In the present study, we sought to analyse the rate of visualization of RT recordings in our first series of patients with the CB-ST device. METHODS AND RESULTS All consecutive patients having undergone CB ablation using CB-ST technology were analysed. Exclusion criteria were the presence of an intracavitary thrombus, uncontrolled heart failure, moderate or severe valvular disease, and contraindications to general anaesthesia. A total of 60 consecutive patients (60.5 ± 11.2 years, 62% males) were evaluated. Real-time recordings were detected in 209 of 240 PVs (87.1%). Specifically, RT recordings could be visualized in 55 left superior PVs (91.7%), 51 left inferior PVs (85.0%), 53 right superior PVs (88.3%), and 50 right inferior PVs (83.3). CONCLUSION The rate of visualization of RT recordings is significantly high during third-generation CB-ST ablation. Real-time recordings can be visualized in ∼87.1% of veins with this novel cryoballoon.


Journal of Cardiovascular Electrophysiology | 2016

Repeat Procedures After Hybrid Thoracoscopic Ablation in the Setting of Longstanding Persistent Atrial Fibrillation: Electrophysiological Findings and 2-Year Clinical Outcome.

Vedran Velagic; F.H.R.S. Carlo De Asmundis M.D.; Giacomo Mugnai; Ghazala Irfan; Burak Hünük; Erwin Ströker; Ebru Hacioglu; Vincent Umbrain; Stefan Beckers; Jens Czapla; Francis Wellens; Jan Nijs; Pedro Brugada; Mark La Meir; Gian-Battista Chierchia

In order to increase success rates of invasive treatment of persistent atrial fibrillation, the hybrid approach was developed, combining video‐assisted thoracoscopic epicardial procedure with conventional endocardial catheter ablation. Currently, there are no reports of electrophysiological findings and clinical outcomes of repeat procedures after the hybrid approach.


Journal of Cardiovascular Medicine | 2017

Learning curve using the second-generation cryoballoon ablation.

Vedran Velagic; Carlo de Asmundis; Giacomo Mugnai; Burak Hünük; Ebru Hacioglu; Erwin Ströker; Darragh Moran; Diego Ruggiero; Jan Poelaert; Christian Verborgh; Vincent Umbrain; Gaetano Paparella; Stefan Beckers; Pedro Brugada; Gian-Battista Chierchia

Aims To study the learning curve with the second-generation cryoballoon technology focusing on safety, efficacy and procedural characteristics. Methods We included 300 patients (men 64.6%, mean age 58.3 ± 12.4 years), 240 of whom were treated by four operators without prior experience in atrial fibrillation ablation and compared them with 60 consecutive patients treated by senior operator. To study the learning curves, we divided the study period into two trimesters and analyzed procedure duration, fluoroscopy times, complications, characteristics of the freeze–thaw cycles and midterm outcomes. Results Hands-on help from senior operators to achieve pulmonary vein isolation was needed only in the first study trimester (24.1%), most commonly to achieve right inferior pulmonary vein isolation (55.2%). The mean procedure duration shortened from 76.7 ± 17.4 to 65.1 ± 11.4 min (P < 0.0001), and fluoroscopy time decreased from 18.5 ± 7.3 to 12.1 ± 4.3 min (P < 0.0001) for first and second trimester, respectively, and approached senior operators results (58.2 ± 12.8 and 8.7 ± 4.5 min). Most of the major complications (one stroke, four pseudoaneurysms and one retroperitoneal hematoma) occurred during the first study trimester. Most characteristics of the freeze cycles remained unchanged in both study periods. Compared with junior operators, the senior operator achieved lower nadir temperatures in both inferior veins. However, there was no significant difference in midterm outcomes between junior and senior operators (79.5 vs 83.3%, P = 0.589). Conclusion The learning curve with the second-generation cryoballoon is steep. Inexperienced operators, trained in high-volume centers, can achieve pulmonary vein isolation safely and efficiently with short procedure and fluoroscopy times after having performed 20–30 cases.

Collaboration


Dive into the Vincent Umbrain's collaboration.

Top Co-Authors

Avatar

Carlo de Asmundis

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pedro Brugada

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar

Erwin Ströker

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar

Giacomo Mugnai

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar

Jan Poelaert

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar

Stefan Beckers

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Darragh Moran

Vrije Universiteit Brussel

View shared research outputs
Top Co-Authors

Avatar

Ebru Hacioglu

Vrije Universiteit Brussel

View shared research outputs
Researchain Logo
Decentralizing Knowledge